Roflumilast Tablet
Product Images NDC 0904-7483

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Roflumilast (NDC 0904-7483). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Major Pharmaceuticals, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

500 Mcg Bottle Label (Image 01)

Label for Roflumilast Tablets 500 mcg by Major Pharmaceuticals, contained in a 90-tablet bottle. The label includes dosage information recommending one 500 mcg tablet orally once daily for adults, storage conditions, and distributor contact details based in Indianapolis, IN.*

FDA Label Image

Roflumilast-fig1 (Roflumilast Fig1)

A pharmacokinetic interaction chart depicting fold changes in Cmax and AUC of Roflumilast and Roflumilast N-oxide relative to reference when co-administered with various drugs. The chart shows that cimetidine, enoxacin, fluvoxamine, ketoconazole, minulet, and erythromycin require use with caution, rifampicin is not recommended, and other drugs like budesonide, digoxin, and warfarin require no dose adjustment.*

FDA Label Image

Roflumilast-structure (Roflumilast Structure)

Chemical structure of roflumilast, showing its molecular components including fluorine atoms, aromatic rings, and other functional groups.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.